Evidence of increased angiogenesis in patients with acute myeloid leukemia

Blood

Volumn 95, Issue 1, 2000, Pages 309-313

  Hussong, Jerry W ^a   Rodgers, George M ^a   Shami, Paul J ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CELL MARKER; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANGIOGENESIS; ARTICLE; BONE MARROW BIOPSY; CANCER GROWTH; CELL STRAIN HL 60; CELL STRAIN U937; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; TUMOR VASCULARIZATION;

EID: 0033957420     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.1.309     Document Type: Article

References (12)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1995;1:27-31.
2. Folkman J. Tumor angiogenesis. In: Holland JR, Frei E, Bast R, Kufe D, Morton D, Weichselbaum R, eds. Cancer Medicine. 4th ed. Baltimore: Williams & Wilkins; 1996:181-204.
3. Iruela-Arispe M, Dvorak H. Angiogenesis: a dynamic balance of stimulators and inhibitors: Thromb Haemost. 1997;78:672-677.
4. Perez-Atayde A, Sallan S, Tedrow U, Connors S, Allred E, Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol. 1997;150: 815-821.
5. Fiedler W, Graeven U, Ergun S, et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood. 1997;89:1870-1875.
6. Nguyen M, Watanabe H, Budson A, Richie J, Jayes D, Folkman J. Elevated levels of an angiogenic peptide, basic fibroblastic growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst. 1994;86:356-361.
7. Asahara T, Bauters C, Zheng LP, et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation. 1995;92(suppl 9):II365-371.
8. Katoh O, Takahashi T, Oguri T, et al. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor. Cancer Res. 1998;58:5565-5569.
9. Bellamy WT, Richter L, Frutiger Y, Grogan TM. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res. 1999;59:728-733.
10. Vacca A, Ribatti D, Roncali L, et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol. 1994;87:503-508.
11. Vacca A, Ribatti D, Roncali L, Dammacco F. Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies. Leuk Lymphoma. 1995;20:27-38.
12. Vacca A, Ribatti D, Iurlaro M, et al. Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis. Int J Clin Lab Res. 1998;28:55-68.